Selatox Bio Pharma announced regulatory approval for a new halal-certified product line, enabling distribution in priority domestic and regional markets where certification is a prerequisite for institutional and retail channels. The approval follows audits of manufacturing, warehousing, and documentation workflows designed to align with national halal requirements and internal governance standards.
Certification scope covers ingredient sourcing, cleaning validation, segregation controls, and transport procedures that prevent commingling with non-certified materials. Quality teams implemented additional label verification steps and reconciliation checks to ensure only approved artwork revisions reach packaging lines.
Commercial organizations are coordinating launch timelines with distribution partners, medical education stakeholders, and customer service teams prepared to address product identification questions. Training modules explain visual identifiers, storage guidance, and reporting channels for suspected quality complaints.
Selatox noted that existing non-certified SKUs remain available where permitted, with clear commercial differentiation to support accurate ordering. Partners are asked to review updated price lists, minimum order quantities, and promotional rules that reflect certification-specific positioning.
For questions regarding certification documentation, partners should contact their regional account manager or regulatory support desk. Selatox will publish FAQ updates on the corporate newsroom as additional markets confirm acceptance of the certified line.
